Terms: = Lymphoma AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
593 results:
1. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing.
Jeon MJ; Yu ES; Kim DS; Choi CW; Kim HN; Kwon JA; Yoon SY; Yoon J
J Clin Lab Anal; 2024 Mar; 38(6):e25027. PubMed ID: 38506403
[TBL] [Abstract] [Full Text] [Related]
3. Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene.
Iwamuro M; Takenaka R; Miyahara K; Okanoue S; Yoshioka M; Sakaguchi C; Yamamoto K; Kawai Y; Toyokawa T; Tanaka T; Otsuka M
Sci Rep; 2024 Feb; 14(1):4953. PubMed ID: 38418651
[TBL] [Abstract] [Full Text] [Related]
4. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
5. Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell lymphoma: Data from the First-in-Human Phase I Study.
Song Y; Jin Z; Li ZM; Liu Y; Li L; He C; Su H; Zhou H; Li K; Hao S; Zuo X; Wu J; Li D; Wu M; Sun X; Qi J; Cai Z; Li Z; Li Y; Huang Y; Shen J; Xiao Z; Zhu J
Clin Cancer Res; 2024 Apr; 30(7):1248-1255. PubMed ID: 38190117
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study.
Okubo S; Shinmura K; Kadota S; Nakayasu M; Kurosawa S; Nakayama H; Sakurai A; Ito C; Aisa Y; Nakazato T
Ann Hematol; 2024 Mar; 103(3):823-831. PubMed ID: 38010408
[TBL] [Abstract] [Full Text] [Related]
8. Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases.
Zerdes I; Kamali C; Koulouris A; Elsayed M; Schnorbach J; Christopoulos P; Tsakonas G
ESMO Open; 2023 Dec; 8(6):102069. PubMed ID: 37988952
[TBL] [Abstract] [Full Text] [Related]
9. prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal lymphoma.
Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Ramsower CA; Rosenthal A; Robetorye RS; Mwangi R; Maurer M; Villa D; McDonnell T; Feldman A; Cohen JB; Habermann T; Campo E; Clot G; Bühler MM; Kulis M; Martin-Subero JI; Giné E; Cook JR; Hill B; Raess PW; Beiske KH; Reichart A; Hartmann S; Holte H; Scott D; Rimsza L
Br J Haematol; 2024 Jan; 204(1):160-170. PubMed ID: 37881141
[TBL] [Abstract] [Full Text] [Related]
11. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
12. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
[TBL] [Abstract] [Full Text] [Related]
14. Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
Wei YC; Qi F; Zheng BM; Zhang CG; Xie Y; Chen B; Liu WX; Liu WP; Fang H; Qi SN; Zhang D; Chai Y; Li YX; Wang WH; Song YQ; Zhu J; Dong M
Int J Cancer; 2023 Nov; 153(9):1643-1657. PubMed ID: 37539660
[TBL] [Abstract] [Full Text] [Related]
15. Gender Differences and miRNAs Expression in Cancer: Implications on prognosis and Susceptibility.
Caserta S; Gangemi S; Murdaca G; Allegra A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511303
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis.
Liu X; Wang M; Wang Q; Zhang H
Breast Cancer Res Treat; 2023 Nov; 202(2):221-231. PubMed ID: 37500963
[TBL] [Abstract] [Full Text] [Related]
17. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis.
Ding Y; Sun C; Hu L; Xiong S; Zhai Z
Ann Hematol; 2023 Sep; 102(9):2425-2434. PubMed ID: 37382610
[TBL] [Abstract] [Full Text] [Related]
19. Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.
Liu X; Cao D; Liu H; Ke X; Liu X; Xu X
Clin Transl Oncol; 2024 Jan; 26(1):214-224. PubMed ID: 37351807
[TBL] [Abstract] [Full Text] [Related]
20. miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options.
Saadi MI; Nikandish M; Ghahramani Z; Valandani FM; Ahmadyan M; Hosseini F; Rahimian Z; Jalali H; Tavasolian F; Abdolyousefi EN; Kheradmand N; Ramzi M
J Egypt Natl Canc Inst; 2023 Jun; 35(1):18. PubMed ID: 37332027
[TBL] [Abstract] [Full Text] [Related]
[Next]
